Hokkaido, Japan

Ayato Takada

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.5

ph-index = 1


Location History:

  • Hokkaido, JP (2020)
  • Sapporo, JP (2021 - 2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Ayato Takada

Introduction

Ayato Takada is a notable inventor from Hokkaido, Japan, with a significant contribution to the field of antiviral research. With four patents to his name, he has focused on developing novel peptides that have potential applications in combating viral infections. His work reflects a deep understanding of biochemistry and molecular biology, positioning him as a key innovator in his domain.

Latest Patents

Among his latest patents, Takada has created several groundbreaking antiviral peptides. The first patent describes a synthetic peptide that features an amino acid sequence represented by specific SEQ ID NOS: 1 to 10. This peptide is designed with a cell-penetrating peptide (CPP) sequence, which enhances its cellular uptake, and comprises a total of not more than 100 amino acid residues.

Another significant patent involves an antiviral peptide that includes a transmembrane region of the G protein of vesicular stomatitis virus (VSV). This invention also employs a CPP sequence, allowing for enhanced delivery of the peptide into cells, thereby potentially improving therapeutic effectiveness against viral pathogens.

Career Highlights

During his career, Ayato Takada has collaborated with esteemed organizations, including Toagosei Company, Ltd. and Hokkaido University. His time at these institutions has laid the groundwork for his innovative research and the development of his patents.

Collaborations

Takada's work has also involved collaboration with notable peers, including Tetsuhiko Yoshida and Nahoko Baileykobayashi. These collaborations have undoubtedly contributed to the innovative nature of his patents, allowing for a sharing of expertise and ideas within the field of antiviral research.

Conclusion

Ayato Takada stands out as a significant figure in the development of antiviral peptides, bringing forth inventions that hold promise for future therapeutic applications. His dedication to innovation and collaboration demonstrates the importance of teamwork in advancing scientific frontiers, making him an inspirational inventor in today's dynamic research landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…